Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
A M EggermontEORTC Melanoma Group

Abstract

We report on the long term outcome of the EORTC 18952 adjuvant interferon (IFN) trial in 1388 resected stage IIB/III melanoma patients and identify key predictive factors for outcome. We analysed outcome of the EORTC 18952 trial (4 weeks of IFN, 10 MU, 5 times/week for 4 weeks followed by 12 months IFN at 10 MU, 3 times/week versus followed by 24 months IFN at 5 MU 3 times/week versus observation) regarding relapse-free survival (RFS), distant metastasis-free interval/survival (DMFI/DMFS), and overall survival (OS), and analysed potential predictive factors of outcome. At a median follow-up of 11 years, the comparison of IFN 13 months versus IFN 25 months versus observation yielded estimated hazard ratios (HR) for RFS of 0.94 versus 0.84 (p = 0.06); for DMFI 0.95 versus 0.82 (p = 0.027); for DMFS 0.95 versus 0.84 (p = 0.07); and for OS 0·95 versus 0.84 (p = 0.08), respectively. The impact of treatment was greatest in the ulceration group, whereas in patients with non-ulcerated primaries the impact was null (HR ≥ 1.0). In patients with ulcerated melanoma the HR for IFN 13 months versus 25 months versus observation were for: RFS 0.82 (p = 0.16) versus 0.61 (p = 0.0008); DMFS 0.76 (p = 0.06) versus 0.57 (p = 0.0003); OS 0.80 (p = ...Continue Reading

References

Aug 23, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A SpatzR L Barnhill
Apr 6, 2006·Journal of the National Cancer Institute·Véronique WinnepenninckxUNKNOWN Melanoma Group of the European Organization for Research and Treatment of Cancer
Jul 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bruce ElliottUNKNOWN European Organization for Research and Treatment of Cancer Melanoma Group
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
May 19, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emanuela RomanoPaul B Chapman
Apr 27, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Augustinus P T van der PloegAlexander M M Eggermont
Nov 8, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alexander M M EggermontAlan Spatz
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander M M EggermontUlrich Keilholz
Sep 24, 2013·Lancet·Alexander M M EggermontCaroline Robert
Oct 1, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Augustinus P T van der PloegAlexander M M Eggermont
May 13, 2015·Seminars in Oncology·Alexander M M EggermontCaroline Robert

❮ Previous
Next ❯

Citations

Apr 14, 2016·Expert Review of Clinical Immunology·Andrea GuennounDavide Bedognetti
Jul 2, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Claus GarbeUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC)
Nov 3, 2016·Annals of Surgical Oncology·Max F MaduAlexander C J van Akkooi
Jul 28, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M C T van ZeijlM W J M Wouters
Jul 28, 2016·Current Treatment Options in Oncology·Kim Margolin
Nov 7, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alexander M M Eggermont
Jun 18, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Leisha A EmensFrancesco M Marincola
Nov 28, 2017·International Journal of Surgery. Oncology·Kara RossfeldGeorgia M Beasley
Oct 9, 2016·The New England Journal of Medicine·Alexander M M EggermontAlessandro Testori
Oct 26, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·P KoelblingerR Dummer
Feb 7, 2019·Cancer Immunology, Immunotherapy : CII·Lorena P Suarez-KellyWilliam E Carson
Feb 13, 2019·International Immunology·Kelly G PaulsonIsaac Brownell
Mar 22, 2019·Melanoma Research·Stephanie A Blankenstein, Alexander C J van Akkooi
Apr 9, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·Daniel G CoitAnita M Engh
Jun 10, 2019·American Journal of Clinical Dermatology·Alessandro A E TestoriMario Mandalà
Oct 28, 2019·Oncoimmunology·Daniëlle VerverAlexander M M Eggermont
Dec 20, 2017·Current Opinion in Oncology·Florentia DimitriouJoanna Mangana
May 21, 2020·FEBS Open Bio·Lisa M HillenVéronique Winnepenninckx
Mar 10, 2017·Expert Opinion on Biological Therapy·Martina SanlorenzoDario Sangiolo
Jan 10, 2017·Frontiers in Immunology·Ekaterina PylaevaJadwiga Jablonska
Apr 2, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rahul SethPauline Funchain
Sep 19, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander M M EggermontCaroline Robert
Nov 17, 2016·Journal of Translational Medicine·Paolo A AsciertoMagdalena Thurin
Apr 17, 2018·The New England Journal of Medicine·Alexander M M EggermontCaroline Robert
Jan 17, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robyn D GartrellYvonne M Saenger
Aug 14, 2019·Seminars in Cancer Biology·Monica MarzagalliEdwin R Manuel
May 31, 2020·Cancer Treatment Reviews·Tara D BaetzTeresa M Petrella
Mar 28, 2021·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F DimitriouA M Menzies
Aug 11, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alexander M M EggermontAlessandro Testori
May 1, 2021·International Journal of Molecular Sciences·Luca TonellaPietro Quaglino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Buruli Ulcer

Buruli ulcer is a progressive disease of subcutaneous tissues caused by mycobacterium ulcerans. Here is the latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Marna G BouwhuisEuropean Organisation for Research and Treatment of Cancer Melanoma Group
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
A M EggermontAlan Spatz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Dimitrios PectasidesHelen Gogas
© 2022 Meta ULC. All rights reserved